Přejít k hlavnímu obsahu
Header image

Jorda Radek

Journals

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,  PDF.
PERINA, M., M. KISS, G. MOTYAN, E. SZCZYRBOVA, M. ELIÁŠ, V. STUDENT, D. KURFÜRSTOVÁ, M. KOVALOVA, L. MADA, J. BOUCHAL, E. FRANK, R. JORDA
A-ring-fused pyrazoles of dihydrotestosterone targeting prostate cancer cells via the downregulation of the androgen receptor. European Journal of Medicinal Chemistry. 2023, 249, 115086, ISSN: 0223-5234, PMID: 36682291,  PDF.
TOMANOVÁ, M., K. KOZLANSKA, R. JORDA, L. JEDINÁK, T. HAVLIKOVA, E. ŘEZNÍČKOVÁ, M. PERINA, P. KLENER, A. DOLNÍKOVÁ, P. CANKAŘ, V. KRYŠTOF
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors. International Journal of Molecular Sciences. 2022, 23(24), 16169, ISSN: 1422-0067, PMID: 36555810,  PDF.